Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Phase I data for guadecitabine plus cisplatin in patients with platinum-refractory GCT

Feb. 18, 2020

Pfizer presents first interim analysis data from TALAPRO-1 study of talazoparib

Feb. 18, 2020

ModraDoc006 shows promising efficacy and safety in phase I study in mCRPC

Feb. 18, 2020

MAO-A inhibitor phenelzine shows promise for treating recurrent prostate cancer

Feb. 17, 2020

Origin story helps ovarian cancer prognosis

Feb. 17, 2020

Domain Therapeutics patents mGluR4 positive allosteric modulators

Feb. 17, 2020

New IDO-1 inhibitors identified at Bristol-Myers Squibb

Feb. 17, 2020

Hinova Pharmaceuticals discovers new BRD4 inhibitors

Feb. 17, 2020

Bayer presents data from phase II/III FORT-1 study of rogaratinib

Feb. 17, 2020

Phase I data presented for fosciclopirox in advanced solid tumors

Feb. 17, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 1, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...